YONGAN PHARMACEUTICAL
00236512.470.16% ( +0.02 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: YONGAN PHARMACEUTICAL(002365) the Revenue is 235.9 M (+37.83%);the EBIT is 10.73 M (+191.1%);the EPS is 0.0268 (+277.5%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.24B37.83%
----
----
EBIT
0.01B191.11%
----
----
EPS
0.0268277.48%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf